These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 15927998
21. False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies. Sahud M, Zhukov O, Mo K, Popov J, Dlott J. Haemophilia; 2012 Sep; 18(5):777-81. PubMed ID: 22458845 [Abstract] [Full Text] [Related]
22. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity. Pengo V, Biasiolo A, Bison E, Chantarangkul V, Tripodi A, Italian Federation of Anticoagulation Clinics (FCSA). Thromb Res; 2007 Sep; 120(1):127-33. PubMed ID: 17020782 [Abstract] [Full Text] [Related]
23. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies. Pengo V, Biasiolo A, Rampazzo P, Brocco T. Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002 [Abstract] [Full Text] [Related]
24. Phospholipid-independent binding of beta 2glycoprotein I by IgA from patients with antiphospholipid syndrome. Galazka MW, Keil LB, Kohles J, Petersheim M, DeBari VA. Ann Clin Lab Sci; 1998 Feb; 28(3):153-9. PubMed ID: 9646856 [Abstract] [Full Text] [Related]
25. [Ischemic stroke with antiphospholipid antibody]. Kitagawa Y, Ohkuma H, Tokuoka K. Brain Nerve; 2008 Oct; 60(10):1144-58. PubMed ID: 18975602 [Abstract] [Full Text] [Related]
26. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. Danowski A, Kickler TS, Petri M. J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938 [Abstract] [Full Text] [Related]
30. Isolation and characterization of two human monoclonal anti-phospholipid IgG from patients with autoimmune disease. von Landenberg C, Lackner KJ, von Landenberg P, Lang B, Schmitz G. J Autoimmun; 1999 Sep; 13(2):215-23. PubMed ID: 10479390 [Abstract] [Full Text] [Related]
31. Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti-coagulant activity. Rolla R, Vidali M, Serino R, Pergolini P, Albano E, Bellomo G. Clin Exp Immunol; 2007 Jul; 149(1):63-9. PubMed ID: 17488295 [Abstract] [Full Text] [Related]
32. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. Jy W, Tiede M, Bidot CJ, Horstman LL, Jimenez JJ, Chirinos J, Ahn YS. Thromb Res; 2007 Jul; 121(3):319-25. PubMed ID: 17582471 [Abstract] [Full Text] [Related]
38. Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk? Galli M. Thromb Res; 2004 Sep; 114(5-6):597-601. PubMed ID: 15507297 [Abstract] [Full Text] [Related]
39. Elevated anti-annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities. Ogawa H, Zhao D, Dlott JS, Cameron GS, Yamazaki M, Hata T, Triplett DA. Am J Clin Pathol; 2000 Oct; 114(4):619-28. PubMed ID: 11026109 [Abstract] [Full Text] [Related]